Christina Ann Johnson
Supervisory Patent Examiner (ID: 1355, Phone: (571)272-1176 , Office: P/1742 )
Most Active Art Unit | 1725 |
Art Unit(s) | 1725, 1791, 1732, 1754, 1742 |
Total Applications | 736 |
Issued Applications | 453 |
Pending Applications | 43 |
Abandoned Applications | 240 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 1073886
[patent_doc_number] => 06838551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Protein AMSH and cDNA thereof'
[patent_app_type] => utility
[patent_app_number] => 10/671572
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2225
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10671572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/671572 | Protein AMSH and cDNA thereof | Sep 28, 2003 | Issued |
Array
(
[id] => 6829752
[patent_doc_number] => 20030180810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Insulin receptor tyrosine kinase substrate'
[patent_app_type] => new
[patent_app_number] => 10/435324
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21574
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10435324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/435324 | Insulin receptor tyrosine kinase substrate | May 8, 2003 | Abandoned |
Array
(
[id] => 6732138
[patent_doc_number] => 20030188328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Human heme-regulated initiation factor 2-alpha kinase'
[patent_app_type] => new
[patent_app_number] => 10/429477
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8002
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20030188328.pdf
[firstpage_image] =>[orig_patent_app_number] => 10429477
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/429477 | Human heme-regulated initiation factor 2-alpha kinase | May 4, 2003 | Abandoned |
Array
(
[id] => 6829827
[patent_doc_number] => 20030180885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'DNA molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby'
[patent_app_type] => new
[patent_app_number] => 10/420845
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12754
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10420845
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/420845 | DNA molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby | Apr 22, 2003 | Abandoned |
Array
(
[id] => 6842912
[patent_doc_number] => 20030148259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Method of identifying insulin secretion stimulating compounds, and the use of such compounds in treating insulin-secretion related disorders'
[patent_app_type] => new
[patent_app_number] => 10/308168
[patent_app_country] => US
[patent_app_date] => 2002-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11378
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10308168
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/308168 | Method of identifying insulin secretion stimulating compounds, and the use of such compounds in treating insulin-secretion related disorders | Dec 2, 2002 | Abandoned |
Array
(
[id] => 6822328
[patent_doc_number] => 20030220489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => '29 human secreted proteins'
[patent_app_type] => new
[patent_app_number] => 10/266829
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 173766
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220489.pdf
[firstpage_image] =>[orig_patent_app_number] => 10266829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/266829 | 29 human secreted proteins | Oct 8, 2002 | Abandoned |
Array
(
[id] => 6765572
[patent_doc_number] => 20030099971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Epidermal differentiation factor'
[patent_app_type] => new
[patent_app_number] => 10/192634
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11719
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192634
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192634 | Epidermal differentiation factor | Jul 10, 2002 | Abandoned |
Array
(
[id] => 6846734
[patent_doc_number] => 20030165901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Human G-protein receptor HGBER32'
[patent_app_type] => new
[patent_app_number] => 10/176078
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12462
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176078
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176078 | Human G-protein receptor HGBER32 | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6830580
[patent_doc_number] => 20030181638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063579
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 45528
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181638.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063579 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 2, 2002 | Abandoned |
Array
(
[id] => 6856983
[patent_doc_number] => 20030130484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Inhibitors and disassemblers of fibrillogenesis'
[patent_app_type] => new
[patent_app_number] => 10/103658
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 41444
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130484.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103658 | Inhibitors and disassemblers of fibrillogenesis | Mar 19, 2002 | Abandoned |
Array
(
[id] => 6432493
[patent_doc_number] => 20020127594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Don-1 gene and polypeptides and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/096241
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24135
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096241 | Don-1 gene and polypeptides and uses therefor | Mar 11, 2002 | Abandoned |
Array
(
[id] => 7134548
[patent_doc_number] => 20040043382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Novel proteins and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 10/092900
[patent_app_country] => US
[patent_app_date] => 2002-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 312805
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043382.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092900 | Novel proteins and nucleic acids encoding same | Mar 6, 2002 | Abandoned |
Array
(
[id] => 968271
[patent_doc_number] => 06939545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Composition and method for treating inflammatory disorders'
[patent_app_type] => utility
[patent_app_number] => 10/084298
[patent_app_country] => US
[patent_app_date] => 2002-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25940
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084298 | Composition and method for treating inflammatory disorders | Feb 24, 2002 | Issued |
09/959235 | Medicaments comprising inhibitors of cell-volume regulated human kinase h-sgk | Feb 18, 2002 | Abandoned |
Array
(
[id] => 5844316
[patent_doc_number] => 20020132301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => '25466, a human transporter family member and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/074547
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 40441
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074547 | 25466, a human transporter family member and uses therefor | Feb 11, 2002 | Issued |
10/048289 | Gene of human brain type pgt | Jan 28, 2002 | Abandoned |
Array
(
[id] => 6791996
[patent_doc_number] => 20030087340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Novel human leucine-rich repeat containing protein expressed predominately in nervous system tissues, HLRRNS1'
[patent_app_type] => new
[patent_app_number] => 10/028392
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 132756
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10028392
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/028392 | Novel human leucine-rich repeat containing protein expressed predominately in nervous system tissues, HLRRNS1 | Dec 19, 2001 | Abandoned |
Array
(
[id] => 972051
[patent_doc_number] => 06936436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/015389
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 249
[patent_figures_cnt] => 249
[patent_no_of_words] => 279529
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015389 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 10, 2001 | Issued |
Array
(
[id] => 6730129
[patent_doc_number] => 20030186319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/015671
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 283582
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015671 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 10, 2001 | Issued |
Array
(
[id] => 6472850
[patent_doc_number] => 20020151472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'TFF peptides'
[patent_app_type] => new
[patent_app_number] => 10/012076
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11865
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151472.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012076
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012076 | TFF peptides | Dec 6, 2001 | Abandoned |